Get started
Author

Sandeep Kumar Mundhra

Observed names: S K Mundhra, S Mundhra, SANDEEP K. MUNDHRA, Sandeep K Mundhra, Sandeep K. Mundhra, Sandeep Mundhra
ORCID: 0000-0002-0953-7168
Observed ORCID: 0000-0002-0953-7168
OpenAlex ID: A5012286417
Stringent screening strategy significantly reduces reactivation rates of tuberculosis in patients with inflammatory bowel disease on anti‐TNF therapy in tuberculosis endemic region
2022 · Peeyush Kumar, Sudheer K. Vuyyuru, et al. · Alimentary Pharmacology & Therapeutics · 27
Minimal risk of lymphoma and non‐melanoma skin cancer despite long‐term use of thiopurines in patients with inflammatory bowel disease: A longitudinal cohort analysis from northern India
2022 · Mukesh Kumar Ranjan, Bhaskar Kante, et al. · Journal of Gastroenterology and Hepatology · 24
A phase I/II clinical trial of ex-vivo expanded human bone marrow derived allogeneic mesenchymal stromal cells in adult patients with perianal fistulizing Crohn’s Disease
2024 · Shekhar Swaroop, Sudheer Kumar Vuyyuru, et al. · Stem Cell Research & Therapy · 17
Coconut Water Induces Clinical Remission in Mild to Moderate Ulcerative Colitis: Double-blind Placebo-controlled Trial
2024 · Saurabh Kedia, Shubi Virmani, et al. · Clinical Gastroenterology and Hepatology · 16
Serum albumin is the strongest predictor of anti-tumor necrosis factor nonresponse in inflammatory bowel disease in resource-constrained regions lacking therapeutic drug monitoring
2023 · Peeyush Kumar, Sudheer K. Vuyyuru, et al. · Intestinal Research · 14
PDF
Low prevalence of Clostridioides difficile infection in acute severe ulcerative colitis: A retrospective cohort study from northern India
2023 · Sandeep Mundhra, David Thomas, et al. · Indian Journal of Gastroenterology · 12
Thiopurines Have Sustained Long-term Effectiveness in Patients with Inflammatory Bowel Disease, Which is Independent of Disease Duration at Initiation: A Propensity Score Matched Analysis
2023 · Mukesh Kumar Ranjan, Peeyush Kumar, et al. · Journal of Crohn s and Colitis · 10
Efficacy and safety of biosimilar versus originator infliximab in patients with inflammatory bowel disease: A real-world cohort analysis
2022 · Peeyush Kumar, Sudheer K. Vuyyuru, et al. · Indian Journal of Gastroenterology · 10
Intravenous Albumin Infusion Does not Augment the Response Rate to a Combination of Exclusive Enteral Nutrition and Intravenous Steroids in Acute Severe Ulcerative Colitis: A Randomised Controlled Trial
2024 · Sandeep K Mundhra, Divya Madan, et al. · Journal of Crohn s and Colitis · 8
Revised Algorithmic Approach to Differentiate Between Nonspecific and Specific Etiologies of Chronic Terminal Ileitis
2023 · Karan Sachdeva, Samagra Agarwal, et al. · The American Journal of Gastroenterology · 8
“Prevalence, Predictors, and Impact of Hepatic Steatosis in Patients With Ulcerative Colitis: A Prospective Observational Cohort Study”
2023 · Arti Gupta, Sudheer K. Vuyyuru, et al. · Journal of Clinical and Experimental Hepatology · 7
PDF
Relapse rates after withdrawal of thiopurines in patients with inflammatory bowel disease
2022 · Mukesh Kumar Ranjan, Sudheer Kumar Vuyyuru, et al. · International Journal of Colorectal Disease · 7
Fecal Microbiota Transplant and Multidrug-Resistant Organism Decolonization in Gastrointestinal Disease: A Randomized Clinical Trial
2026 · Himanshu Narang, Daizee Talukdar, et al. · JAMA Internal Medicine · 5
Incidence of intestinal & extra-intestinal cancers among individuals with Crohn’s disease in northern India
2024 · Parth Sharma, Varad Putambekar, et al. · The Indian Journal of Medical Research · 3
PDF
High seroprevalence against SARS-CoV-2 in non-vaccinated patients with inflammatory bowel disease from Northern India
2023 · Bhaskar Kante, Sudheer Kumar Vuyyuru, et al. · Indian Journal of Gastroenterology · 3
PDF
Methodological insights into fecal microbiota transplantation: Dissecting key approaches for success
2026 · Sandeep K Mundhra, Rakesh Kochhar · World Journal of Methodology · 1
Bridging the language and cultural gap: Translating and validating patient-reported outcomes in regional languages
2025 · Sandeep Kumar Mundhra, Rajni Sharma, et al. · Indian Journal of Gastroenterology · 1
PDF
P1000 A quasi-experimental study evaluating effectiveness of partial enteral nutrition combined with exclusion diet in patients with mild to moderately severe ulcerative colitis
2025 · S Vuyyuru, D Madan, et al. · Journal of Crohn s and Colitis · 1
PDF
Combined or High Dose Immunosuppression in Inflammatory Bowel Disease patients who are NUDT15 Homozygous Harbors Risk of Developing Invasive Fungal Infections: A Case Series
2024 · David Mathew Thomas, Sandeep Kumar Mundhra, et al. · Inflammatory Bowel Diseases · 1
PDF
P531 Stringent screening strategy significantly reduces reactivation rate of Tuberculosis in Patients with Inflammatory Bowel Disease on anti-TNF therapy in a TB endemic region
2022 · P Kumar, S K Vuyyuru, et al. · Journal of Crohn s and Colitis · 1
PDF
P423 Azathioprine still remains the first step-up therapy in patients with Inflammatory Bowel Disease in low-middle income countries
2022 · M K Ranjan, P Kumar, et al. · Journal of Crohn s and Colitis · 1
P720 Similar risk of infection with SARS-CoV-2 in immunocompromised and immunocompetent patients with inflammatory bowel disease and healthy controls
2022 · B Kante, S K Vuyyuru, et al. · Journal of Crohn s and Colitis · 1
Dual therapy with tofacitinib and steroids for acute severe ulcerative colitis: a randomized double-blind placebo-controlled trial
2026 · Umang Arora, Mahak Verma, et al. · Journal of Crohn s and Colitis
Endoscopic management of intestinal strictures in Crohn’s disease: Current status and future perspectives
2026 · Sandeep K Mundhra, Anupam K Singh, et al. · World Journal of Gastrointestinal Endoscopy
PDF
Partial enteral nutrition combined with an exclusion diet promotes a healthy gut microbiome in patients with mild to moderately active ulcerative colitis: A quasi-experimental study
2026 · Sudheer K Vuyyuru, Divya Madan, et al. · Crohn s & Colitis 360
Works count: 43
Citation count: 178
H-index: 8
I10-index: 8
Year
Topic
Type